https://www.selleckchem.com/products/rmc-4550.html
Dynamic uric acid monitoring has been achieved using the presented biosensor. And the obtained results in serum samples had no significant difference compared with those obtained using the FDA-approved electrochemical analyzer (Paired T-test, p 0.05). These demonstrated that the technology can potentially be applied in POC monitoring of other biomolecules to improve prognosis, diagnosis and treatment outcomes of metabolic diseases.Detection of cellular microRNA biomarkers is an emerging powerful tool in cancer diagnostics. Current
Like
Comment
Share
